Deals and ownership · Procter & Gamble Co PG
P&G: stock awards and executive sales — distinct transactions
P&G executives received stock awards and associated instruments; separate disclosures detail sales of a portion of shares. For shareholders, it is important to distinguish awarded compensation from purchases with personal funds.
How ownership changed
Chief Executive Officer Shailesh Jejurikar received a grant of 16,065 shares and 191,909 derivative securities. These categories should be counted separately: a derivative security does not represent an existing ordinary share, while a grant entails the company providing shares (or derivative securities), not a market purchase.
Separately — completed sales
Susan Whaley sold 2,369 shares, leaving 30,729.9685 shares after the transaction. Paul Gama sold 2,225 shares, leaving 51,123.8803 shares. This reduces their holdings but does not constitute a full exit.
How to use this information
Disclosures enable tracking of awards and changes in executives’ positions. The grant and sale should be analyzed together with the remaining holdings, rather than treating all transactions as the same signal for shareholders.
Where the evidence ends
The reasons for the disclosed sales are unknown from these filings. They do not demonstrate a deterioration in the business, and receiving an award does not prove that the executive voluntarily increased personal risk.
What to check next
Future disclosures should be matched against remaining share balances and award terms. Assessing P&G itself requires separate financial results; the executive transaction table does not replace them.
Prepared from official company documents with the help of AI and checked automatically and editorially: every number in the text matches the original source. This is not investment advice.